newsfilter
← Latest News
GlobeNewswire·

CytomX Therapeutics to Report Third Quarter 2026 Financial Results on November 5, 2026

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report third